Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BH3I-1 (BHI1) is a Bcl-2 antagonist.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 7,000 | |||
2 mg | 在庫あり | ¥ 9,000 | |||
5 mg | 在庫あり | ¥ 14,500 | |||
10 mg | 在庫あり | ¥ 22,500 | |||
25 mg | 在庫あり | ¥ 45,500 | |||
50 mg | 在庫あり | ¥ 77,500 | |||
100 mg | 在庫あり | ¥ 129,500 |
説明 | BH3I-1 (BHI1) is a Bcl-2 antagonist. |
ターゲット&IC50 | BH3-BCL XL:2.4 μM(Ki), MDM2-p53:5.3 μM(Kd) |
In vitro | BH3I-1 inhibits Bcl-xL heterodimerization in vitro. It also induces cytochrome c release[1]. BH3I-1, while inhibiting its reported target Bcl-2/Bim and Bcl-xL/Bim, shows significant inhibition of both the p53/hDM2 and p300/Hif-1a interactions[2]. |
細胞研究 | Cells (5×104 cells per well) are seeded into white 96-well plates (Costar) and treated with various concentrations of the compounds for 48 h. For zVAD-FMK protection experiments, cells are preincubated with 100 μM zVAD-FMK for 1 h before the addition of chemicals. Cell viability is determined with an MTS assay. For PI staining experiments, cells are grown in 24-well plates and then incubated with 2 μg ml/L PI. Cell death is determined by FACS analysis.(Only for Reference) |
別名 | BHI1 |
分子量 | 400.31 |
分子式 | C15H14BrNO3S2 |
CAS No. | 300817-68-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 60 mg/mL (149.9 mM)
Ethanol: 11 mg/mL (27.5 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BH3I-1 300817-68-9 Apoptosis Ubiquitination E1/E2/E3 Enzyme BCL MDM-2/p53 BH3I 1 BHI-1 Inhibitor Ubiquitin ligase E3 ligating enzyme Ubiquitin conjugating enzyme BH3I1 E2 conjugating enzyme Bcl-2 Family BHI1 E1 activating enzyme inhibit BH 3I1 BHI 1 Ubiquitin activating enzyme BH-3I-1 inhibitor